Fig. 3From: Up-regulation of MTHFD2 is associated with clinicopathological characteristics and poor survival in ovarian cancer, possibly by regulating MOB1A signalingGenetic alterations of MTHFD2 in ovarian cancer subgroups. Subgroup analysis of multiple clinic pathologic features of ovarian cancer samples in the TCGA. A rases; B Ages; C TP53-Mutant; D stagesBack to article page